Application note

# Application note: Tipping point – what is driving the adoption of rFC for bacterial endotoxin testing?

Published: 21 October 2022

Over the last 20 years, the worldwide value of traded pharmaceutical goods has grown six‑fold, from $113 billion in 2000 to$629 billion in 2019. Yet amid such robust growth comes risk to supply chain security as manufacturers become increasingly dependent on a global network of suppliers. In a recent McKinsey Global Institute survey, nearly 50 percent of respondents cited sole sourcing of inputs as a critical vulnerability – and 25 percent pointed to a lack of visibility of supplier risks.